Article

Addition of nitrous oxide anesthesia: stress reduction during cataract surgery

Author(s):

Investigators conducted a retrospective consecutive study in which they compared the outcomes using this approach with the results achieved with local anesthesia alone during cataract surgery.

Addition of nitrous oxide anesthesia: stress reduction during cataract surgery

Nitrous oxide may help to suppress intraoperative anxiety and memory and decrease and stabilize vital signs.

Japanese physicians reported that the use of a low concentration of nitrous oxide anesthesia during cataract surgery, along with local anesthesia, did not result in respiratory depression, abnormal vital signs, or nausea. This application may be useful to suppress intraoperative anxiety and memory and decrease and stabilize vital signs, according to first author Santaro Noguchi, MD, from the Department of Ophthalmology, Saneikai Tsukazaki Hospital, Himeji, Japan.

Patients were included who underwent bilateral cataract surgeries. The investigators reviewed the cases of 37 patients for whom room air inhalation (air group) was used and the cases of 45 patients for whom 30% low-concentration nitrous oxide anesthesia (70% oxygen, total 6 L/min) at the start of surgery (nitrous oxide group) was used.

The investigators monitored the systolic and diastolic blood pressure levels and heart rates at the beginning and end of surgery and the mean oxygen saturation (% SpO2) intraoperatively. The patients completed a questionnaire immediately postoperatively regarding the intraoperative pain, anxiety, memory, and nausea measured using the Visual Analogue Scale.

Nitrous oxide effects

The investigators reported that no patients had systemic symptoms or ocular complications that required treatment.

All of the changes observed between the nitrous oxide and air groups reached significance. The respective changes in the blood pressures were −5.38 ± 11.07 and 1.27 ± 13.61 mmHg (p=0.01); the changes in heart rates were −2.24 ± 6.76 and 0.89 ± 5.18 beats/minute (p=0.001); the intraoperative SpO2 levels were 99.05% ± 0.74% and 97.44% ± 1.31% (p<0.001); the intraoperative anxiety levels were 21.76 ± 23.2 and 37.17 ± 32.79 (p=0.002); and the intraoperative memory values were 55.24 ± 36.8 and 68.91 ± 33.81 (p=0.01). No nausea was experienced intraoperatively by any patients. No significant differences were seen in the diastolic blood pressures and degrees of intraoperative pain.

Based on these results, the authors concluded, “Low-concentration [nitrous oxide] anesthesia may not cause respiratory depression, abnormal vital signs, or nausea during cataract surgery. [Nitrous oxide] can suppress intraoperative anxiety and memory and decrease and stabilize vital signs.”

Reference
  1. Noguchi S, Nakakura S, Noguchi A, et al. Examination of the safety and effectiveness of low-concentration nitrous oxide anesthesia in cataract surgery. J Cataract Refract Surg.July 15, 2021.doi: 10.1097/j.jcrs.0000000000000749

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.